This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT庐 through assessment of patient-reported symptoms, 网红黑料-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal鈥
39 publications
2024
The American journal of tropical medicine and hygiene
鈥2023
The Laryngoscope
鈥2023
Cureus
鈥2022
American journal of rhinology & allergy
鈥2022
Laryngoscope Investigative Otolaryngology